COVID-19 Vaccinations in Trial Participants: Should this happen or not?
Webinar - Free Q&A Session
Description
| Event | Webinar |
| Type | Virtual Event |
| Language | English |
| Date(s) | 15 Feb. 2021 |
| Day(s) | 17:00 - 18:00 |
| Duration | 1 hour |
Our Free of Charge weekly Q&A Webinars on Clinical Trials During the Corona Virus Pandemic are continuing!
Quality and ethics experts respond to your questions from sponsor and site points of view.
COVID-19 Vaccinations in Trial Participants: Should this happen or not?
Programme
| 17:00 |
Opening of the Webinar Moderator(s): Mark Poulton, Poulton Quality Solutions |
|
Introduction
Heather Sampson, University of Toronto
|
|
|
Ethical and Methodological Considerations
Beat Widler, WS QMS
|
|
|
What are the problems when a trial participant is given the opportunity to be given an approved vaccine?
Seif Eddine Amara Madi, GSK
|
|
|
Panel Discussion: What are the problems when a trial participant is given the opportunity to participate in a COVID-19 vaccine clinical trial?
Cathy Dove, Dove Quality Solutions
David Haerry, Patvocates
Louise Mawer, Mirabilitas
Sarah Hall, Mipsol Ltd
Sylvia Kranich, SK Consulting
|
|
| 18:00 |
End of the Webinar |